Results 11 to 20 of about 1,346,163 (252)

Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literature

open access: yesJournal of Medical Case Reports, 2019
Background Sclerosing mucoepidermoid carcinoma with eosinophilia is a rare form of thyroid carcinoma. The underlying molecular mechanisms of sclerosing mucoepidermoid carcinoma with eosinophilia tumorigenesis remain unknown.
Jasmine S. Sukumar   +6 more
doaj   +2 more sources

Infarcted Warthin tumor with mucoepidermoid carcinoma-like metaplasia: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2019
Background Warthin tumor is a common, benign, painless salivary gland neoplasm. Rarely, Warthin tumors show large areas of squamous metaplasia; such Warthin tumors are called metaplastic or infarcted Warthin tumors because they are occasionally ...
Kenji Yorita   +5 more
doaj   +2 more sources

Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Protein phosphatase 2A (PP2A) is a ubiquitous serine/threonine phosphatase that mediates cell cycle regulation and metabolism. Mounting evidence has indicated that PP2A inhibition exhibits considerable anticancer potency in multiple ...
Limin Liu   +13 more
doaj   +2 more sources

Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors

open access: yesBiomedicines, 2023
Introduction: Salivary gland carcinomas (SGC) are histologically diverse cancers and next-generation sequencing (NGS) to identify key molecular targets is an important aspect in the management of advanced cases.
M. Bou Zerdan   +5 more
semanticscholar   +1 more source

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

open access: yesJCI Insight, 2021
No effective systemic treatment is available for patients with unresectable, recurrent, or metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy.
Zirong Chen   +14 more
semanticscholar   +1 more source

Advances in the Treatment of Mucoepidermoid Carcinoma

open access: yesWorld Journal of Oncology, 2021
Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their low incidence, it is challenging to conduct clinical trials and develop treatment guidelines.
S. Sama, T. Komiya, A. Guddati
semanticscholar   +1 more source

NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case

open access: yesVirchows Archiv, 2021
Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) is an exceedingly rare low-grade thyroid malignancy of unknown histogenesis. NUT carcinoma is another rare, highly aggressive neoplasm with predilection for the midline, defined by recurrent ...
A. Agaimy   +6 more
semanticscholar   +1 more source

MUCOEPIDERMOID CARCINOMA OF THE BRONCHUS

open access: yesPediatric Hematology and Oncology, 2000
Bronchoscopy in a 4.5-year-old girl with recurrent pneumonia showed an exophytic endobronchial mass. Biopsy disclosed microscopic and ultrastructural features of a low-grade mucoepidermoid carcinoma. Complete cure was accomplished by surgical removal of the tumor and right lower lobe.
Dinopoulos, A   +4 more
openaire   +3 more sources

Predominantly cystic central mucoepidermoid carcinoma developing from a previously diagnosed dentigerous cyst: case report and review of the literature

open access: yesClinics and Practice, 2013
Primary intraosseous mucoepidermoid carcinoma of the jawbones is an extremely rare malignant salivary gland tumour constituting 2- 4.3% of all the reported mucoepidermoid carcinomas.
Banavar Ravi Spoorthi   +5 more
doaj   +1 more source

Outcomes and prognostic factors in parotid gland malignancies: A 10-year single center experience. [PDF]

open access: yes, 2019
Objectives:To describe a 10-year single center experience with parotid gland malignancies and to determine factors affecting outcomes. Study Design:Retrospective review.
Bulbul, Mustafa   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy